Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Growth Small Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Dreyfus/The Boston Company Small Cap Growth Fund

+ Add to Watchlist

SSYGX:US

40.08 USD 0.11 0.27%

As of 09:29:30 ET on 04/24/2015.

Snapshot for Dreyfus/The Boston Company Small Cap Growth Fund (SSYGX)

Year To Date: +10.17% 3-Month: +10.81% 3-Year: - 52-Week Range: 32.72 - 40.19
1-Month: +3.09% 1-Year: +17.72% 5-Year: - Beta vs RUO: 1.02

Mutual Fund Chart for SSYGX

No chart data available.
  • SSYGX:US 40.08
  • 1M
  • 1Y
Interactive SSYGX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SSYGX

Dreyfus/The Boston Company Small Cap Growth Fund is an open-end fund incorporated in the USA. The Fund's objective seeks long-term growth of capital. The Fund invests all of its investible assets in a Standish master portfolio which invests, under normal circumstances, at least 80% of net assets in equity securities of small cap U.S. companies.

Inception Date: 07-01-2013 Telephone: 1-800-346-8893 Domestic
Managers: TODD W WAKEFIELD / ROBERT ZEUTHEN
Web Site: www.dreyfus.com

Fundamentals for SSYGX

NAV (on 2015-04-24) 40.08
Assets (M) (on 2015-04-24) 26.95
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment 0.00

Dividends for SSYGX

No dividends reported

Fees & Expenses for SSYGX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.80
Redemption Fee -
12b1 Fee -
Expense Ratio 0.95

Top Fund Holdings for SSYGX

Filing Date: 02/28/2015
Name Position Value % of Total
iShares Russell 2000 Growth ET 9,360 1,396,044 4.865%
Watsco Inc 4,813 564,276 1.966%
Celldex Therapeutics Inc 20,217 516,342 1.799%
WuXi PharmaTech Cayman Inc 12,809 511,720 1.783%
Inter Parfums Inc 17,714 503,609 1.755%
Anacor Pharmaceuticals Inc 11,185 486,548 1.696%
LogMeIn Inc 9,031 475,934 1.659%
KYTHERA Biopharmaceuticals Inc 11,396 473,504 1.650%
BioDelivery Sciences Internati 31,530 472,792 1.648%
Beacon Roofing Supply Inc 15,172 455,463 1.587%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil